Idursulfase
CAS 50936-59-9Biologic
Overview
Idursulfase is a recombinant formulation of the human enzyme iduronate-2-sulfatase, used to treat Hunter syndrome, a rare, inherited disorder. It works by replacing the deficient or absent enzyme in individuals with the condition, thus helping to reduce the accumulation of glycosaminoglycans.
Therapeutic areas
Metabolic Disorders
Verified Supplier Partner
Do you supply Idursulfase? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.